Condition: Pancreatic Cancer · Pancreatic Carcinoma · Pancreatic Adenocarcinoma · Sponsor: City of Hope Medical Center
This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.
This description comes directly from the study's public registry record.
Ajay Goel, PhD · 6262183452 · AJGOEL@COH.ORG
Always discuss trial participation with your own doctor first.
| Translational Genomics Research Institute | Phoenix, Arizona, United States | Recruiting |
| Honorhealth | Scottsdale, Arizona, United States | Recruiting |
| City of Hope Medical Center | Monrovia, California, United States | Recruiting |
| Hoag Center | Newport Beach, California, United States | Recruiting |
| OSF HealthCare | Peoria, Illinois, United States | Recruiting |
| Ochsner Medical Center | Jefferson, Louisiana, United States | Recruiting |
| Atlantic Health System | Morristown, New Jersey, United States | Recruiting |
| Piedmont Medical Center | Rock Hill, South Carolina, United States | Recruiting |
| Medical College of Wisconsin | Milwaukee, Wisconsin, United States | Recruiting |
| Nagoya University | Nagoya, Japan | Recruiting |
| Asan Medical Center | Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06388967